Bss Ophthalmic Solution in 2026: What's the Supply Situation?

If you're scheduled for eye surgery in 2026, you may have heard about supply issues with Bss Ophthalmic Solution — the sterile Balanced Salt Solution used in virtually every ophthalmic surgical procedure. Shortages of BSS have been an ongoing concern for years, affecting patients, surgeons, and surgical centers across the country.

In this article, we'll give you the latest update on where things stand, what's driving the supply issues, and what you can do to protect your surgical timeline.

Is Bss Ophthalmic Solution Still in Shortage?

As of early 2026, Bss Ophthalmic Solution is not on the FDA's official drug shortage list, but that doesn't tell the whole story. Supply remains intermittently tight, with many surgical centers reporting periodic difficulty sourcing BSS products — particularly standard BSS Sterile Irrigating Solution in 15 mL and 30 mL sizes.

The situation varies by region and by distributor. Some ambulatory surgery centers (ASCs) have adequate supply, while others face backorders lasting weeks. The picture changes frequently, which makes real-time tracking tools essential.

For tips on locating supply, see How to Find Bss Ophthalmic Solution in Stock Near You.

Why Is Bss Ophthalmic Solution Hard to Find?

The supply challenges trace back to several factors that have been building for years:

A Narrow Manufacturing Base

In 2008, the FDA issued enforcement actions against companies manufacturing unapproved versions of Balanced Salt Solution — including B. Braun, Baxter, and Hospira. This left Alcon Laboratories as the dominant FDA-approved manufacturer of BSS and BSS Plus. When you have essentially one major supplier for a product used in over 4 million cataract surgeries per year, any production disruption creates a cascade.

Growing Demand

The U.S. population is aging, and eye surgeries are increasing every year. The American Academy of Ophthalmology estimates over 4 million cataract procedures annually in the U.S., plus hundreds of thousands of corneal, glaucoma, and retinal surgeries — all requiring BSS.

Supply Chain Fragility

Manufacturing sterile ophthalmic solutions requires specialized facilities and rigorous quality controls. Raw material sourcing, equipment maintenance, and regulatory inspections can all impact production timelines. Global logistics challenges in recent years have only made things harder.

For a deeper dive, read Why Is Bss Ophthalmic Solution So Hard to Find? [Explained for 2026].

What Does Bss Ophthalmic Solution Cost in 2026?

Because BSS is a surgical product — not a retail pharmacy medication — its cost works differently than most prescriptions:

• BSS Sterile Irrigating Solution (15 mL): Approximately $8 to $25 per bottle when purchased through medical supply distributors
• BSS Plus (500 mL): Approximately $35 to $90 per bottle
• Generic Balanced Salt Solution (500 mL): $15 to $50 for institutional purchasers

For patients, BSS cost is almost always bundled into the surgical facility fee and covered under your medical insurance (not pharmacy benefit). You typically won't see a separate line item for BSS on your bill. However, if supply issues force your surgical center to use a more expensive product like BSS Plus, the facility absorbs that cost difference in most cases.

For more on managing costs, see How to Save Money on Bss Ophthalmic Solution in 2026.

Are There New Options in 2026?

The market for ophthalmic irrigating solutions is slowly diversifying:

• ZEISS Puri Clear: ZEISS has entered the BSS market with its own balanced salt solution, offering surgical centers another sourcing option.
• Navstel: This enriched balanced salt solution with hypromellose, dextrose, and glutathione remains available as an alternative to BSS Plus.
• Endosol Extra: Another FDA-approved option that some centers keep as a backup supply.

The entry of new manufacturers is a positive development, but Alcon still controls the majority of the market. It will take time for competitors to build the production capacity needed to truly diversify the supply base.

For a full rundown of alternatives, see Alternatives to Bss Ophthalmic Solution If You Can't Fill Your Prescription.

How to Find Bss Ophthalmic Solution in Stock Right Now

If you or your surgical center are looking for BSS, here are the most effective strategies:

1. Use Medfinder: Search Medfinder for real-time availability data on Bss Ophthalmic Solution near your location.
2. Contact your surgeon's office early: Ask about BSS supply at your pre-op appointment, not the day of surgery.
3. Check multiple facilities: Different surgical centers use different distributors. If one is experiencing a backorder, another may have stock.
4. Ask about alternatives: Your surgeon can determine whether BSS Plus, Endosol Extra, or Navstel is appropriate for your procedure.

For a step-by-step guide, see How to Check If a Pharmacy Has Bss Ophthalmic Solution in Stock.

Final Thoughts

The Bss Ophthalmic Solution supply situation in 2026 is best described as manageable but unpredictable. Supply is generally available but subject to periodic disruptions that can catch patients and surgical centers off guard.

The best defense is preparation: ask early, stay informed, and know your alternatives. New manufacturers entering the market and improved supply chain management at surgical centers are gradually improving the picture, but it's still worth being proactive.

Visit Medfinder to search for Bss Ophthalmic Solution availability in your area, and bookmark this page for future updates throughout 2026.